2013
DOI: 10.1098/rsif.2013.0297
|View full text |Cite
|
Sign up to set email alerts
|

Engineering the acyltransferase substrate specificity of assembly line polyketide synthases

Abstract: Polyketide natural products act as a broad range of therapeutics, including antibiotics, immunosuppressants and anti-cancer agents. This therapeutic diversity stems from the structural diversity of these small molecules, many of which are produced in an assembly line manner by modular polyketide synthases. The acyltransferase (AT) domains of these megasynthases are responsible for selection and incorporation of simple monomeric building blocks, and are thus responsible for a large amount of the resulting polyk… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
114
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 107 publications
(119 citation statements)
references
References 128 publications
(257 reference statements)
0
114
0
Order By: Relevance
“…In modular type I PKSs, functional domains are organized into several modules, with each module being responsible Insights into biosynthetic mechanisms of polyketides only achieved considerable progress from 1953 when Birch and Donovan hypothesized a potential biosynthetic pathway similar to that of fatty acids [9]. Further advancements in the polyketide field led to the consensus that polyketides are typically biosynthesized through successive decarboxylative condensations of coenzyme A (CoA)-derived units, into a complex polycyclic multi-carbon compound containing keto or hydroxyl groups [10]. Downstream modifying enzymes are then used to obtain flavonoids and other bioactive substances.…”
Section: Introductionmentioning
confidence: 99%
“…In modular type I PKSs, functional domains are organized into several modules, with each module being responsible Insights into biosynthetic mechanisms of polyketides only achieved considerable progress from 1953 when Birch and Donovan hypothesized a potential biosynthetic pathway similar to that of fatty acids [9]. Further advancements in the polyketide field led to the consensus that polyketides are typically biosynthesized through successive decarboxylative condensations of coenzyme A (CoA)-derived units, into a complex polycyclic multi-carbon compound containing keto or hydroxyl groups [10]. Downstream modifying enzymes are then used to obtain flavonoids and other bioactive substances.…”
Section: Introductionmentioning
confidence: 99%
“…Some ATs were reported to recognize ACP-bound substrates such as methoxymalonyl-, hydroxymalonyl-, and aminomalonyl-ACP (3,4). Thus, ATs are key determinants of building block specificity in polyketide biosynthesis and attractive targets to change the substrate specificity to obtain biologically active unnatural polyketide products (5). However, the substitution of an AT domain by a homologous AT domain possessing different substrate specificity resulted in reduced or abolished production of polyketide analogs in many cases, probably because of disruption of proper protein-protein interactions or the inability of downstream modules to process polyketide analogs (5,6).…”
mentioning
confidence: 99%
“…Based on such knowledge, various strategies such as domain swap, domain hybrid, site-directed mutagenesis and trans-AT complementation that were reviewed by Dunn and Khosla [27] can be used to modify the AT domains to select an "unnatural" starter or extender unit. This review summarizes some new cases about AT domain modification in recent years.…”
Section: At Domainmentioning
confidence: 99%